Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Evans

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Seminars in Oncology|December 1, 1986
High-dose megestrol acetate therapy of ovarian carcinoma: a phase II study by the Northern California Oncology GroupB I Sikic, S A Scudder, S C Ballon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
Phase II randomized trial of carboplatin, paclitaxel, bevacizumab with or without cixutumumab (IMC-A12) in patients with advanced non-squamous, non-small-cell lung cancer: a trial of the ECOG-ACRIN Cancer Research Group (E3508)A Argiris, J W Lee, J Stevenson, et al.
ESMO Open|March 11, 2023
A single-arm, multicenter, phase II trial of osimertinib in patients with epidermal growth factor receptor exon 18 G719X, exon 20 S768I, or exon 21 L861Q mutationsL C Villaruz, X Wang, E M Bertino, et al.
Science (New York, N.Y.)|December 18, 2015
Geomorphic and geologic controls of geohazards induced by Nepal's 2015 Gorkha earthquakeJ S Kargel, G J Leonard, D H Shugar, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Seminars in Oncology|December 1, 1986
High-dose megestrol acetate therapy of ovarian carcinoma: a phase II study by the Northern California Oncology GroupB I Sikic, S A Scudder, S C Ballon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
Phase II randomized trial of carboplatin, paclitaxel, bevacizumab with or without cixutumumab (IMC-A12) in patients with advanced non-squamous, non-small-cell lung cancer: a trial of the ECOG-ACRIN Cancer Research Group (E3508)A Argiris, J W Lee, J Stevenson, et al.
ESMO Open|March 11, 2023
A single-arm, multicenter, phase II trial of osimertinib in patients with epidermal growth factor receptor exon 18 G719X, exon 20 S768I, or exon 21 L861Q mutationsL C Villaruz, X Wang, E M Bertino, et al.
Science (New York, N.Y.)|December 18, 2015
Geomorphic and geologic controls of geohazards induced by Nepal's 2015 Gorkha earthquakeJ S Kargel, G J Leonard, D H Shugar, et al.
Pageof 3